Mesa Laboratories, Inc. logo

MLAB

Mesa Laboratories, Inc.

$196.69

Earnings Summary

Revenue
$50.45Mn
Net Profits
$-1.44Mn
Net Profit Margins
-2.85%
PE Ratio
587.24

Highlights

Revenue:

Mesa Laboratories, Inc.’s revenue jumped 44.48% since last year same period to $50.45Mn in the Q2 2022. On a quarterly growth basis, Mesa Laboratories, Inc. has generated -14.31% fall in its revenue since last 3-months.

Net Profits:

Mesa Laboratories, Inc.’s net profit fell -172.08% since last year same period to $-1.44Mn in the Q2 2022. On a quarterly growth basis, Mesa Laboratories, Inc. has generated 19.39% jump in its net profits since last 3-months.

Net Profit Margins:

Mesa Laboratories, Inc.’s net profit margin fell -149.89% since last year same period to -2.85% in the Q2 2022. On a quarterly growth basis, Mesa Laboratories, Inc. has generated 5.93% jump in its net profit margins since last 3-months.

PE Ratio:

Mesa Laboratories, Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 587.24.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Mesa Laboratories, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.99
EPS Estimate Current Year
0.99

Highlights

EPS Estimate Current Quarter:

Mesa Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.99 - a 106.25% jump from last quarter’s estimates.

EPS Estimate Current Year:

Mesa Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 0.99.

Key Ratios

Key ratios of the Mesa Laboratories, Inc. post its Q2 2022 earnings

Return on Assets (ROA)
0.01
Return on Equity (ROE)
-0
Dividend Per Share (DPS)
0.64

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Mesa Laboratories, Inc.’s return on assets (ROA) stands at 0.01.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Mesa Laboratories, Inc.’s return on equity (ROE) stands at -0.

Dividend Per Share (DPS):

Mesa Laboratories, Inc. declared 0.64 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-31
0.48
-0.34
-170.83%

Company Information

Mesa Labs is a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, medical device, industrial safety, environmental, and food and beverage industries. Mesa offers products and services through four divisions (Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments and Continuous Monitoring) to help its customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.

Organisation
Mesa Laboratories, Inc.
Headquarters
Lakewood, Colorado, United States
Employees
506
Industry
Medical Specialties
CEO
Gary Owens